<DOC>
	<DOCNO>NCT00867217</DOCNO>
	<brief_summary>The primary purpose determine high dose vitamin D3 reduce incidence musculoskeletal symptom associate aromatase inhibitor letrozole woman early stage breast cancer low serum vitamin D level . The primary hypothesis high dose vitamin D3 prevent worsen musculoskeletal symptom compare standard dose vitamin D3 treatment .</brief_summary>
	<brief_title>Vitamin D3 Aromatase Inhibitor Induced Arthralgias</brief_title>
	<detailed_description>This protocol examine relationship vitamin D level ( 25-hydroxyvitamin D ) various quality life measure woman treat letrozole standard care early stage breast cancer .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Postmenopausal woman newly diagnose early stage breast cancer , would treat aromatase inhibitor Serum 25OHD level &lt; 40 ng/ml Severe debilitate musculoskeletal pain Known metastatic disease History renal stone History hypercalcemia hyperthyroidism Currently receive adjuvant neoadjuvant chemotherapy Currently receive investigational agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>